Enzyme Replacement Therapy Medicines
Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
- Published
- 15 August 2024
- Estimated value
- £6,079,596
- Place of performance
- UKM
- Procedure
- Direct award
- Lots
- 1
- Notice number
- 025941-2024
- Reference
- ocds-h6vhtk-047918
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
Supply of Enzyme Replacement Therapy Medicines (e-g) to NHS Scotland: - NP92624(e) Velaglucerase alfa 400units powder for solution for infusion vials 1 vial (VPRIV®) - NP92624(f) Idursulfase 6mg/3ml solution for infusion vials 1 vial (Elaprase®) - NP92624(g) Agalsidase alfa 3.5mg/3.5ml solution for infusion vials 1 vial (Replagal®)
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Takeda UK Limited | — | — |
Official publications
- FTS · 025941-2024 · 15 August 2024
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £6,079,596.
- Who is the buyer of this tender?
- The contracting authority is The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Get alerts for tenders like this
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.